| 111.51 1.25 (1.13%) | 10-14 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 133.03 | 1-year : | 155.38 |
| Resists | First : | 113.9 | Second : | 133.03 |
| Pivot price | 111.24 |
|||
| Supports | First : | 108.8 |
Second : | 105.66 |
| MAs | MA(5) : | 111.15  |
MA(20) : | 110.47 |
| MA(100) : | 105.18 |
MA(250) : | 106.25 |
|
| MACD | MACD : | 1 |
Signal : | 1.2 |
| %K %D | K(14,3) : | 55.5 |
D(3) : | 58.3 |
| RSI | RSI(14): 57.8 |
|||
| 52-week | High : | 115.44 | Low : | 96.94 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ AFL ] has closed below upper band by 43.7%. Bollinger Bands are 24.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 111.82 - 112.56 | 112.56 - 113.23 |
| Low: | 108.04 - 108.99 | 108.99 - 109.86 |
| Close: | 110.04 - 111.54 | 111.54 - 112.9 |
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.
Mon, 13 Oct 2025
Aflac’s (AFL) Global Reach and its Long-Standing Record as a Dividend Aristocrat - Yahoo Finance
Mon, 13 Oct 2025
Concord Asset Management LLC VA Boosts Stake in Aflac Incorporated $AFL - MarketBeat
Mon, 13 Oct 2025
Aflac Incorporated $AFL Stock Position Trimmed by Vest Financial LLC - MarketBeat
Mon, 13 Oct 2025
Aberdeen Group plc Has $45.52 Million Stock Holdings in Aflac Incorporated $AFL - MarketBeat
Sun, 12 Oct 2025
Sather Financial Group Inc Takes $316,000 Position in Aflac Incorporated $AFL - MarketBeat
Sun, 12 Oct 2025
Aflac Incorporated $AFL Stock Position Lifted by Callan Family Office LLC - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Insurance - Life
|
|
| Shares Out | 535 (M) |
| Shares Float | 530 (M) |
| Held by Insiders | 10.5 (%) |
| Held by Institutions | 59.6 (%) |
| Shares Short | 7,520 (K) |
| Shares Short P.Month | 7,600 (K) |
| EPS | 4.44 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 50.86 |
| Profit Margin | 15.3 % |
| Operating Margin | 21 % |
| Return on Assets (ttm) | 1.7 % |
| Return on Equity (ttm) | 9.1 % |
| Qtrly Rev. Growth | -19 % |
| Gross Profit (p.s.) | 12.3 |
| Sales Per Share | 29.74 |
| EBITDA (p.s.) | 6.45 |
| Qtrly Earnings Growth | -64.2 % |
| Operating Cash Flow | 2,590 (M) |
| Levered Free Cash Flow | 4,040 (M) |
| PE Ratio | 25.11 |
| PEG Ratio | 0 |
| Price to Book value | 2.19 |
| Price to Sales | 3.74 |
| Price to Cash Flow | 23.02 |
| Dividend | 0.57 |
| Forward Dividend | 0 |
| Dividend Yield | 0.5% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|